Natus Medical (NASDAQ:BABY) was downgraded by stock analysts at William Blair from an “outperform” rating to a “market perform” rating in a report released on Monday, Marketbeat reports.
A number of other analysts also recently commented on the stock. BidaskClub downgraded shares of Natus Medical from a “sell” rating to a “strong sell” rating in a report on Saturday. Zacks Investment Research downgraded shares of Natus Medical from a “buy” rating to a “hold” rating in a report on Tuesday, December 26th. One analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company’s stock. Natus Medical currently has a consensus rating of “Hold” and an average target price of $46.50.
Natus Medical (NASDAQ:BABY) traded down $1.40 on Monday, hitting $29.00. 1,964,800 shares of the company traded hands, compared to its average volume of 1,104,200. Natus Medical has a 52-week low of $28.85 and a 52-week high of $43.60. The company has a debt-to-equity ratio of 0.36, a quick ratio of 3.36 and a current ratio of 4.21. The firm has a market cap of $903.47, a P/E ratio of -483.33 and a beta of 0.84.
In other news, VP Dong Chune Christopher Chung sold 12,642 shares of the stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $42.91, for a total value of $542,468.22. Following the completion of the sale, the vice president now owns 141,414 shares of the company’s stock, valued at approximately $6,068,074.74. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director William M. Moore sold 5,000 shares of the stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $41.01, for a total transaction of $205,050.00. The disclosure for this sale can be found here. 5.50% of the stock is currently owned by corporate insiders.
Several institutional investors have recently bought and sold shares of BABY. Benjamin F. Edwards & Company Inc. grew its stake in shares of Natus Medical by 2,085.6% in the 3rd quarter. Benjamin F. Edwards & Company Inc. now owns 2,732 shares of the medical equipment provider’s stock valued at $102,000 after buying an additional 2,607 shares during the period. Riverhead Capital Management LLC grew its stake in shares of Natus Medical by 90.9% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,864 shares of the medical equipment provider’s stock valued at $107,000 after buying an additional 1,364 shares during the period. Sei Investments Co. grew its stake in shares of Natus Medical by 29.7% in the 2nd quarter. Sei Investments Co. now owns 3,182 shares of the medical equipment provider’s stock valued at $119,000 after buying an additional 728 shares during the period. SG Americas Securities LLC purchased a new stake in shares of Natus Medical in the 3rd quarter valued at approximately $138,000. Finally, Victory Capital Management Inc. grew its stake in shares of Natus Medical by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 3,744 shares of the medical equipment provider’s stock valued at $140,000 after buying an additional 560 shares during the period. 99.94% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “William Blair Lowers Natus Medical (BABY) to Market Perform” was originally posted by Markets Daily and is owned by of Markets Daily. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://www.themarketsdaily.com/2018/01/10/william-blair-lowers-natus-medical-baby-to-market-perform.html.
About Natus Medical
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.